Open-label Phase 2 study of Ladiratuzumab Vedotin (LV) for unresectable locally advanced or metastatic solid tumors [SGNLVA-005]

  • Richardson, Gary (Primary Chief Investigator (PCI))
  • Baker, Emma (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date13/05/2031/12/21

Keywords

  • Medical oncology
  • Clinical trial